Wonkwang University Sanbon Hospital
Welcome,         Profile    Billing    Logout  
 13 Trials 
23 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Lee, Eun Bong
Aladdin, NCT04618640: To Evaluate the Immunogenicity and Safety of DTaP-IPV Vaccine Administered as a Boosting Dose to Healthy Children of 4-6 Years

Recruiting
3
249
RoW
DTaP-IPV combination vaccine
Boryung Biopharma Co., Ltd.
Diphtheria, Tetanus, Pertussis, Poliomyelitis
12/20
07/21
NCT05313061: MTX Hold During Covid-19 Booster

Recruiting
3
40
RoW
MTX
Seoul National University Hospital
Rheumatoid Arthritis
12/22
12/22
LIBRETTO-531, NCT04211337 / 2019-001978-28: A Study of Selpercatinib (LY3527723) in Participants With RET-Mutant Medullary Thyroid Cancer

Active, not recruiting
3
291
Europe, Canada, Japan, US, RoW
Selpercatinib, LY3527723, LOXO-292, Cabozantinib, Vandetanib
Loxo Oncology, Inc., Eli Lilly and Company
Medullary Thyroid Cancer
05/23
02/26
NCT05317858: Blood-brain Barrier (BBB) Disruption Using Exablate Focused Ultrasound With Standard of Care Treatment of NSCLC Brain Mets

Recruiting
3
20
Canada, US, RoW
Blood Brain Barrier Disruption - Oncology, Exablate BBBD, Pembrolizumab
InSightec
Brain Tumor
06/24
12/24
NCT05757102: A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma

Recruiting
3
292
US, RoW
FF/UMEC/VI, ELLIPTA, FF/VI
GlaxoSmithKline
Asthma
01/27
01/27
NCT06001606: Immunogenicity, Reactogenicity of Shingrix in SLE

Recruiting
3
63
RoW
Shingrix, Placebo
Seoul National University Hospital
Zoster, Systemic Lupus Erythematosus, Vaccine Reaction
04/25
04/25
TETON-2, NCT05255991 / 2021-005881-17: Multinational Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis

Active, not recruiting
3
597
Europe, RoW
Placebo, Inhaled Treprostinil, Tyvaso, Treprostinil Ultrasonic Nebulizer
United Therapeutics
Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease
07/25
07/25
SHINE-2, NCT05784246: A Study of Mirikizumab (LY3074828) in Pediatric Participants With Moderately to Severely or Active Ulcerative Colitis

Recruiting
3
60
Europe, Canada, Japan, US, RoW
Mirikizumab IV, LY3074828, Mirikizumab SC
Eli Lilly and Company
Ulcerative Colitis
07/26
03/27
OPTIMAL, NCT03315364 / 2020-000954-86: Oral Paclitaxel Trial In Recurrent and Metastatic Breast Cancer As 1st Line Therapy

Active, not recruiting
2/3
549
Europe, RoW
Oral paclitaxel, Liporaxel®, Paclitaxel injection, Taxol®
Daehwa Pharmaceutical Co., Ltd., Daehwa pharmaceutical Co., Ltd.
Recurrent or Metastatic Breast Cancer
02/24
12/25
NAVIGATE, NCT04365868 / 2019-001983-31: Study Evaluating the Efficacy and Safety of Belapectin for the Prevention of Esophageal Varices in NASH Cirrhosis

Active, not recruiting
2b
357
Europe, Canada, US, RoW
belapectin, GR-MD-02, galactoarabino rhamnogalacturonate, Placebo
Galectin Therapeutics Inc., Galectin Therapeutics Inc
Prevention of Esophageal Varices, NASH - Nonalcoholic Steatohepatitis, Cirrhosis
12/24
12/24
NCT05032066: A Multicenter Trial to Evaluate the Efficacy, Safety and Tolerability of HZN-825 in Subjects With Idiopathic Pulmonary Fibrosis

Jan 2024 - Dec 2024: Data from trial for diffuse cutaneous systemic sclerosis
Terminated
2
153
Europe, Canada, Japan, US, RoW
HZN-825, Placebo
Amgen
Idiopathic Pulmonary Fibrosis
07/24
01/25
AFFINITY, NCT04573920: Atrasentan in Patients With Proteinuric Glomerular Diseases

Active, not recruiting
2
103
Europe, US, RoW
Atrasentan, CHK-01, Atrasentan Hydrochloride, ABT-627
Novartis Pharmaceuticals
IgA Nephropathy, Focal Segmental Glomerulosclerosis, Alport Syndrome, Diabetic Kidney Disease, Diabetic Nephropathy Type 2, Immunoglobulin A Nephropathy
07/24
07/26
WILLOW, NCT05162586 / 2021-004648-27: The Study With M5049 in SLE and CLE (SCLE and/or DLE)

Hourglass Oct 2024 - Dec 2024 : Data for SLE
Hourglass Jul 2024 - Sep 2024 : Data for CLE
Completed
2
456
Europe, Japan, US, RoW
Enpatoran low dose, M5049, Enpatoran medium dose, Enpatoran high dose, Placebo
EMD Serono Research & Development Institute, Inc., Merck KGaA, Darmstadt, Germany
Systemic Lupus Erythematosus
11/24
11/24
BBT877-IPF-004, NCT05483907: To Evaluate the Efficacy, Safety, and Tolerability of BBT-877 in Patients with IPF

Hourglass Jul 2023 - Dec 2023 : Interim data for the treatment of IPF
Checkmark Initiation of trial in idiopathic pulmonary fibrosis
Nov 2022 - Nov 2022: Initiation of trial in idiopathic pulmonary fibrosis
Active, not recruiting
2
129
Europe, US, RoW
BBT-877, Placebo
Bridge Biotherapeutics, Inc.
Idiopathic Pulmonary Fibrosis
01/25
09/25
WILLOW LTE, NCT05540327 / 2022-000239-21: The Willow LTE Study With M5049 in Participants With SCLE, DLE and/or SLE

Recruiting
2
532
Europe, Japan, US, RoW
M5049 low dose, Enpatoran, M5049 medium dose, M5049 high dose, Placebo, M5049 very high dose
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany, Merck Healthcare KGaA
Systemic Lupus Erythematosus
04/25
04/25
ECHO, NCT03062072: Emergence of Chemotherapy Related Hyperglycemia in nOn-diabetic Patients

Recruiting
N/A
300
RoW
Chemotherapy, cytotoxic chemotherapeutic agents
National Cancer Center, Korea, SMG-SNU Boramae Medical Center
Cancer, Colon Cancer, Breast Cancer, Malignant Lymphoma
12/17
12/22
MUST-BE, NCT02909426: The Mammography and Ultrasonography STudy for Breast Cancer Screening Effectiveness

Active, not recruiting
N/A
11880
RoW
Ultrasonography, Digital mammography
Soonchunhyang University Hospital, Ministry of Health & Welfare, Korea
Invasive Cancer, Ductal Carcinoma in Situ
12/20
12/23
VALENTINE, NCT04874246: Comparison of Concentration of Vasopressin During Robot-assisted Laparoscopic Myomectomy

Completed
N/A
39
RoW
Vasopressin, Vasopressin 20U
Seoul National University Hospital, CHA University
Uterine Leiomyoma
12/21
12/22
MAeSTroⅡ, NCT06261190: Active Surveillance for Low-risk Papillary Thyroid Carcinoma

Enrolling by invitation
N/A
499
RoW
National Cancer Center, Korea, Seoul National University Bundang Hospital, SMG-SNU Boramae Medical Center, Seoul National University Hospital
Thyroid Cancer, Papillary Thyroid Carcinoma
12/29
12/32
KOBIO, NCT01965132: Korean College of Rheumatology Biologics and Targeted Therapy Registry

Recruiting
N/A
10000
RoW
Biologic or targeted synthetic DMARD, etanercept, adalimumab, infliximab, golimumab, tocilizumab, abatacept, rituximab, ustekinumab, secukinumab, ixekizumab, or biosimilars, tofacitinib, baricitinib, upadacitinib
Seoul National University Hospital
Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis
12/29
06/30
NCT05848271: Natural History Study of Patients With HPDL Mutations

Recruiting
N/A
50
US
Patient Registry, Dry blood spots sampling
University of California, San Diego, New York University, Universität Tübingen, Heinrich-Heine University, Duesseldorf
Mitochondrial Encephalomyopathies, Hereditary Spastic Paraplegia, Spastic Paraplegia, White Matter Disease, Neonatal Encephalopathy, Mutation, Genetic Disease
12/24
12/24
MAeSTroⅡ-SDM, NCT06730893: Shared Decision-Making for Determining Treatment Strategies in Low-Risk Thyroid Cancer

Not yet recruiting
N/A
294
NA
share decision aids
National Cancer Center, Korea, Seoul National University Hospital, Seoul National University Bundang Hospital, SMG-SNU Boramae Medical Center, Nowon Eulji Medical Center, Hanyang University
Thyroid Cancer, Papillary Thyroid Carcinoma
12/27
12/27
NCT05241041: Effects of Positive Psychological Group Psychotherapy and Auricular Acupressure on Withdrawal Symptoms

Recruiting
N/A
240
RoW
group counseling, auricular acupressure, placebo acupressure
Inha University Hospital, National Research Foundation of Korea
Gambling
02/25
02/26

Download Options